COVID-19 Fear and Anxiety in Patients with Diabetes Mellitus and their Effect on HbA1c

TURA BAHADIR, Çiğdem; OZÇETINKAYA ERDOGAN, SERAP

doi:10.32552/2022.ActaMedica.810

COVID-19 Fear and Anxiety in Patients with Diabetes Mellitus and their Effect on HbA1c

Çiğdem TURA BAHADIR, (Amasya Üniversitesi Tıp Fakültesi Anabilim Dalı Endokrinoloji ve Metabolizma, Amasya, Türkiye.)

SERAP OZÇETINKAYA ERDOGAN (Amasya Üniversitesi Tıp Fakültesi Anabilim Dalı Psikiyatri, Amasya, Türkiye)

Acta Medica

13 4

Yıl: 2023 Cilt: 54 Sayı: 1 Sayfa Aralığı: 22 - 26 Metin Dili: İngilizce DOI: 10.32552/2022.ActaMedica.810 İndeks Tarihi: 30-05-2023

COVID-19 Fear and Anxiety in Patients with Diabetes Mellitus and their Effect on HbA1c

Öz:

Objective: To determine the severity of fear and anxiety of COVID-19 in diabetic patients and to evaluate their relationship with HbA1c. Materials and methods: Between December 2020 and March 2021, a total of 249 patients were included in the study. Demographic characteristics, duration of diabetes, glycosylated hemoglobin A1c (HbA1c) values of the patients were recorded. Fear and anxiety related to COVID-19 were evaluated with the validated Turkish version of the Fear of COVID Scale (FCS) and Coronavirus Anxiety Scale (CAS). FCS and CAS were compared between the diabetic group and the control group. The relationship between FCS and CAS and HbA1c, diabetes year, age, gender, educational status, place of residence, and employment status was investigated. Results: Median level of HbA1c and duration of diabetes mellitus were 7.65% (range 5.4-13.6) and 10 years (range 1-32) respectively. FCS was higher in the diabetic group compared to the control group (p=0.025). There was no significant difference between the diabetic and control groups regarding CAS. There was no relationship between HbA1c and FCS and CAS (p=0.919, r=0.008, p=0.725, r=0.027, respectively). Anxiety was higher in females than males in diabetic groups (p=0.009). Conclusions: The fear of COVID-19 is higher in diabetic patients compared to the general population. There was no relationship between fear and anxiety of COVID-19 and HbA1c. However, to protect long-term mental health, there should be strategies to detect and reduce the anxiety and fear caused by the pandemic in the services for diabetic patients.

Anahtar Kelime:

Belge Türü: Makale Makale Türü: Araştırma Makalesi Erişim Türü: Erişime Açık

[1] Guo W, M Li, Y Dong, H Zhou, Z Zhang, C Tian, R Qin, H Wang, Y Shen, K Du, L Zhao, H Fan, S Luo, D Hu. Diabetes is a risk factor for the progression and prognosis of COVID-19. Diabetes Metab Res Rev. 2020; e3319.
[2] Joensen LE, KP Madsen, L Holm, KA Nielsen, MH Rod, AA Petersen, NH Rod, I Willaing. Diabetes and COVID-19: psychosocial consequences of the COVID-19 pandemic in people with diabetes in Denmark-what characterizes people with high levels of COVID-19-related worries? Diabet Med. 2020; 37:1146-54.
[3] Alessi J, GB de Oliveira, DW Franco, B Brino do Amaral, AS Becker, CP Knijnik, GL Kobe, TR de Carvalho, GH Telo, BD Schaan, GH Telo. Mental health in the era of COVID-19: prevalence of psychiatric disorders in a cohort of patients with type 1 and type 2 diabetes during the social distancing. Diabetol Metab Syndr. 2020; 12:76.
[4] Brooks SK, RK Webster, LE Smith, L Woodland, S Wessely, N Greenberg, GJ Rubin. The psychological impact of quarantine and how to reduce it: rapid review of the evidence. Lancet. 2020; 395:912-20.
[5] Mukhtar S and S Mukhtar. Letter to the Editor: Mental Health and Psychological Distress in People with Diabetes during COVID-19. Metabolism. 2020; 108:154248.
[6] Piskinpasa H, Turgut S, Karaarslan O, Bozkur E, Esen A, Pamuk N, Cakir I, Mert M, D SC. Disease Activity is Associated with Depression and Anxiety in Cushing’s Syndrome During COVID-19 Pandemic. Turk J Endocrinol Metab. 2021; 25:166-73.
[7] Al-Sofiani ME, S Albunyan, AM Alguwaihes, RR Kalyani, SH Golden, A Alfadda. Determinants of mental health outcomes among people with and without diabetes during the COVID-19 outbreak in the Arab Gulf Region. J Diabetes. 2020; 13:339-52.
[8] Ruissen MM, H Regeer, CP Landstra, M Schroijen, I Jazet, MF Nijhoff, H Pijl, B Ballieux, O Dekkers, SD Huisman, EJP de Koning. Increased stress, weight gain and less exercise in relation to glycemic control in people with type 1 and type 2 diabetes during the COVID-19 pandemic. BMJ Open Diabetes Res Care. 2021; 9:e002035.
[9] Gonder-Frederick LA, WR Carter, DJ Cox, WL Clarke. Environmental stress and blood glucose change in insulindependent diabetes mellitus. Health Psychol. 1990; 9:503- 15.
[10] Faulenbach M, H Uthoff, K Schwegler, GA Spinas, C Schmid, P Wiesli. Effect of psychological stress on glucose control in patients with Type 2 diabetes. Diabet Med. 2012; 29:128-31.
[11] Halford WK, S Cuddihy, RH Mortimer. Psychological stress and blood glucose regulation in type I diabetic patients. Health Psychol. 1990; 9:516-28.
[12] Bakioğlu F, O Korkmaz, H Ercan. Fear of COVID-19 and Positivity: Mediating Role of Intolerance of Uncertainty, Depression, Anxiety, and Stress. Int J Ment Health Addict. 2020; 1-14.
[13] Evren C, B Evren, E Dalbudak, M Topcu, N Kutlu. Measuring anxiety related to COVID-19: A Turkish validation study of the Coronavirus Anxiety Scale. Death Stud. 2020; 1-7.
[14] Satici B, E Gocet-Tekin, ME Deniz, SA Satici. Adaptation of the Fear of COVID-19 Scale: Its Association with Psychological Distress and Life Satisfaction in Turkey. Int J Ment Health Addict. 2020; 1-9.
[15] Ahorsu DK, CY Lin, V Imani, M Saffari, MD Griffiths, AH Pakpour. The Fear of COVID-19 Scale: Development and Initial Validation. Int J Ment Health Addict. 2020; 1-9.
[16] Lee SA. Coronavirus Anxiety Scale: A brief mental health screener for COVID-19 related anxiety. Death Stud. 2020; 44:393-401.
[17] Collins MM, P Corcoran, IJ Perry. Anxiety and depression symptoms in patients with diabetes. Diabet Med. 2009; 26:153-61.
[18] Wang C, R Pan, X Wan, Y Tan, L Xu, CS Ho, RC Ho. Immediate Psychological Responses and Associated Factors during the Initial Stage of the 2019 Coronavirus Disease (COVID-19) Epidemic among the General Population in China. Int J Environ Res Public Health. 2020; 17:1729.
[19] Ausín B, C González-Sanguino, MÁ Castellanos, M Muñoz. Gender-related differences in the psychological impact of confinement as a consequence of COVID-19 in Spain. Journal of Gender Studies. 2021; 30:29-38.
[20] Bajor LA, D Gunzler, D Einstadter, C Thomas, R McCormick, AT Perzynski, SW Kanuch, KA Cassidy, NV Dawson, M Sajatovic. Associations between comorbid anxiety, diabetes control, and overall medical burden in patients with serious mental illness and diabetes. Int J Psychiatry Med. 2015; 49:309-20.

APA	TURA BAHADIR Ç, OZÇETINKAYA ERDOGAN S (2023). COVID-19 Fear and Anxiety in Patients with Diabetes Mellitus and their Effect on HbA1c. , 22 - 26. 10.32552/2022.ActaMedica.810
Chicago	TURA BAHADIR Çiğdem,OZÇETINKAYA ERDOGAN SERAP COVID-19 Fear and Anxiety in Patients with Diabetes Mellitus and their Effect on HbA1c. (2023): 22 - 26. 10.32552/2022.ActaMedica.810
MLA	TURA BAHADIR Çiğdem,OZÇETINKAYA ERDOGAN SERAP COVID-19 Fear and Anxiety in Patients with Diabetes Mellitus and their Effect on HbA1c. , 2023, ss.22 - 26. 10.32552/2022.ActaMedica.810
AMA	TURA BAHADIR Ç,OZÇETINKAYA ERDOGAN S COVID-19 Fear and Anxiety in Patients with Diabetes Mellitus and their Effect on HbA1c. . 2023; 22 - 26. 10.32552/2022.ActaMedica.810
Vancouver	TURA BAHADIR Ç,OZÇETINKAYA ERDOGAN S COVID-19 Fear and Anxiety in Patients with Diabetes Mellitus and their Effect on HbA1c. . 2023; 22 - 26. 10.32552/2022.ActaMedica.810
IEEE	TURA BAHADIR Ç,OZÇETINKAYA ERDOGAN S "COVID-19 Fear and Anxiety in Patients with Diabetes Mellitus and their Effect on HbA1c." , ss.22 - 26, 2023. 10.32552/2022.ActaMedica.810
ISNAD	TURA BAHADIR, Çiğdem - OZÇETINKAYA ERDOGAN, SERAP. "COVID-19 Fear and Anxiety in Patients with Diabetes Mellitus and their Effect on HbA1c". (2023), 22-26. https://doi.org/10.32552/2022.ActaMedica.810

APA	TURA BAHADIR Ç, OZÇETINKAYA ERDOGAN S (2023). COVID-19 Fear and Anxiety in Patients with Diabetes Mellitus and their Effect on HbA1c. Acta Medica, 54(1), 22 - 26. 10.32552/2022.ActaMedica.810
Chicago	TURA BAHADIR Çiğdem,OZÇETINKAYA ERDOGAN SERAP COVID-19 Fear and Anxiety in Patients with Diabetes Mellitus and their Effect on HbA1c. Acta Medica 54, no.1 (2023): 22 - 26. 10.32552/2022.ActaMedica.810
MLA	TURA BAHADIR Çiğdem,OZÇETINKAYA ERDOGAN SERAP COVID-19 Fear and Anxiety in Patients with Diabetes Mellitus and their Effect on HbA1c. Acta Medica, vol.54, no.1, 2023, ss.22 - 26. 10.32552/2022.ActaMedica.810
AMA	TURA BAHADIR Ç,OZÇETINKAYA ERDOGAN S COVID-19 Fear and Anxiety in Patients with Diabetes Mellitus and their Effect on HbA1c. Acta Medica. 2023; 54(1): 22 - 26. 10.32552/2022.ActaMedica.810
Vancouver	TURA BAHADIR Ç,OZÇETINKAYA ERDOGAN S COVID-19 Fear and Anxiety in Patients with Diabetes Mellitus and their Effect on HbA1c. Acta Medica. 2023; 54(1): 22 - 26. 10.32552/2022.ActaMedica.810
IEEE	TURA BAHADIR Ç,OZÇETINKAYA ERDOGAN S "COVID-19 Fear and Anxiety in Patients with Diabetes Mellitus and their Effect on HbA1c." Acta Medica, 54, ss.22 - 26, 2023. 10.32552/2022.ActaMedica.810
ISNAD	TURA BAHADIR, Çiğdem - OZÇETINKAYA ERDOGAN, SERAP. "COVID-19 Fear and Anxiety in Patients with Diabetes Mellitus and their Effect on HbA1c". Acta Medica 54/1 (2023), 22-26. https://doi.org/10.32552/2022.ActaMedica.810